Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz


1. 14396-16-8
2. Piperazine 2-hydroxypropane-1,2,3-tricarboxylate
3. 2-hydroxypropane-1,2,3-tricarboxylic Acid;piperazine
4. Piperazinecitrate
5. Oxyzin (syrup)
6. Piperazine Citrate (1:1)
7. Schembl125278
8. Dtxsid20921081
9. Amy40769
10. Nsc86779
11. Piperazine Compound With Citric Acid
12. Nsc203336
13. Akos015920444
14. Gs-3869
15. Nsc-203336
16. Piperazine,2,3-propanetricarboxylate (3:2)
17. E75921
18. A808202
19. 2-hydroxypropane-1,2,3-tricarboxylic Acid--piperazine (1/1)
20. Wln: T6m Dmtj & 3 & 622 & Qv1xqvq1vq & 2 & 621
21. 113484-97-2
| Molecular Weight | 278.26 g/mol |
|---|---|
| Molecular Formula | C10H18N2O7 |
| Hydrogen Bond Donor Count | 6 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 5 |
| Exact Mass | 278.11140092 g/mol |
| Monoisotopic Mass | 278.11140092 g/mol |
| Topological Polar Surface Area | 156 Ų |
| Heavy Atom Count | 19 |
| Formal Charge | 0 |
| Complexity | 254 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Related Excipient Companies
Excipients by Applications
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
100
PharmaCompass offers a list of Piperazine Citrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Piperazine Citrate manufacturer or Piperazine Citrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Piperazine Citrate manufacturer or Piperazine Citrate supplier.
A 3C6H8O7.3C4H10N2.H2O manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 3C6H8O7.3C4H10N2.H2O, including repackagers and relabelers. The FDA regulates 3C6H8O7.3C4H10N2.H2O manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 3C6H8O7.3C4H10N2.H2O API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 3C6H8O7.3C4H10N2.H2O manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A 3C6H8O7.3C4H10N2.H2O supplier is an individual or a company that provides 3C6H8O7.3C4H10N2.H2O active pharmaceutical ingredient (API) or 3C6H8O7.3C4H10N2.H2O finished formulations upon request. The 3C6H8O7.3C4H10N2.H2O suppliers may include 3C6H8O7.3C4H10N2.H2O API manufacturers, exporters, distributors and traders.
click here to find a list of 3C6H8O7.3C4H10N2.H2O suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing 3C6H8O7.3C4H10N2.H2O as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for 3C6H8O7.3C4H10N2.H2O API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture 3C6H8O7.3C4H10N2.H2O as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain 3C6H8O7.3C4H10N2.H2O and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a 3C6H8O7.3C4H10N2.H2O NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of 3C6H8O7.3C4H10N2.H2O suppliers with NDC on PharmaCompass.
3C6H8O7.3C4H10N2.H2O Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 3C6H8O7.3C4H10N2.H2O GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right 3C6H8O7.3C4H10N2.H2O GMP manufacturer or 3C6H8O7.3C4H10N2.H2O GMP API supplier for your needs.
A 3C6H8O7.3C4H10N2.H2O CoA (Certificate of Analysis) is a formal document that attests to 3C6H8O7.3C4H10N2.H2O's compliance with 3C6H8O7.3C4H10N2.H2O specifications and serves as a tool for batch-level quality control.
3C6H8O7.3C4H10N2.H2O CoA mostly includes findings from lab analyses of a specific batch. For each 3C6H8O7.3C4H10N2.H2O CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
3C6H8O7.3C4H10N2.H2O may be tested according to a variety of international standards, such as European Pharmacopoeia (3C6H8O7.3C4H10N2.H2O EP), 3C6H8O7.3C4H10N2.H2O JP (Japanese Pharmacopeia) and the US Pharmacopoeia (3C6H8O7.3C4H10N2.H2O USP).